Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use

Show simple item record

dc.contributor.author Marshall, Sarah
dc.contributor.author Sahm, Laura J.
dc.contributor.author Moore, Anne C.
dc.date.accessioned 2019-09-20T11:01:08Z
dc.date.available 2019-09-20T11:01:08Z
dc.date.issued 2016-02-03
dc.identifier.citation Marshall, S., Sahm, L. J. and Moore, A. C. (2016) 'Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use', Vaccine, 34(6), pp. 723-34. doi: 10.1016/j.vaccine.2015.12.002 en
dc.identifier.volume 34 en
dc.identifier.issued 6 en
dc.identifier.startpage 723 en
dc.identifier.endpage 734 en
dc.identifier.issn 1873-2518
dc.identifier.issn 0264-410X
dc.identifier.uri http://hdl.handle.net/10468/8586
dc.identifier.doi 10.1016/j.vaccine.2015.12.002 en
dc.description.abstract Objective: To examine published research which explores the perception and acceptability of microneedle technology for immunisation and to investigate the suitability of this technology for paediatric use. Methods: A series of keywords and their synonyms were combined in various combinations and permutations using Boolean operators to sequentially search four databases (PubMed, Web of Science, Embase and CINAHL). Following removal of duplications and irrelevant results, 12 research articles were included in the final literature review. Results: The opinions of patients, parents, children and healthcare professionals (HCP) were collated. A positive perception and a high level of acceptability predominated. Conclusion: Microneedle technology research has been focussed on demonstrating efficacy with minimal focus on determining HCP/public perception and acceptability for paediatric use, exemplified by the paucity of studies presented in this review. Commercial viability will depend on HCP/public acceptability of microneedle technology. An effort must be made to identify the barriers to acceptance and to overcome them by increasing awareness and education in stakeholder groups pertaining to the paediatric population. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Elsevier Ltd. en
dc.rights © 2016, Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license. en
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/ en
dc.subject Acceptability en
dc.subject Immunisation en
dc.subject Microneedle en
dc.subject Paediatric en
dc.subject Perception en
dc.title Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Anne Moore, Biochemistry & Cell Biology, University College Cork, Cork, Ireland. +353-21-490-3000 Email: anne.moore@ucc.ie en
dc.internal.availability Full text available en
dc.date.updated 2019-09-20T10:28:14Z
dc.description.version Accepted Version en
dc.internal.rssid 391944502
dc.description.status Peer reviewed en
dc.identifier.journaltitle Vaccine en
dc.internal.copyrightchecked Yes
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress anne.moore@ucc.ie en
dc.internal.IRISemailaddress l.sahm@ucc.ie en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2016, Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license. Except where otherwise noted, this item's license is described as © 2016, Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement